Austal Limited (ASB) ORDINARY FULLY PAID |
Industrials |
$2,144 |
H1 FY2025 Results Investor Presentation
|
21 Feb 2025 8:20AM |
$3.570 |
$5.090 |
risen by
42.58%
|
|
ASB - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue for H1 FY2025 reached $826 million, a 15% increase.
- Operating cash flow of $238 million demonstrates strong cash generation.
- Net cash position improved to $213 million, providing growth flexibility.
- Order book increased to $14.2 billion, including options.
- Earnings driven by recovery in U.S. build programs.
- Investment in submarine modules and strategic shipbuilding agreements underway.
- Guidance for FY2025 EBIT updated to a minimum of $80 million.
- Company expects further growth through increased order volume and technology advancements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Austal Limited (ASB) ORDINARY FULLY PAID |
Industrials |
$2,144 |
H1 FY2025 Results Announcement
|
21 Feb 2025 8:20AM |
$3.570 |
$5.090 |
risen by
42.58%
|
|
ASB - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 15.1% to $825.7 million.
- EBIT rose to $42.7 million from $32.1 million in FY2024 H1.
- Net profit after tax increased by 108.9% to $25.1 million.
- Closing cash position improved to $212.6 million.
- Awarded US$450 million contract by General Dynamics Electric Boat.
- Awarded US$152 million contract by US Navy for infrastructure investment.
- Record order book of $14.2 billion.
- Positive outlook for FY2025 with updated EBIT guidance not less than $80 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Austal Limited (ASB) ORDINARY FULLY PAID |
Industrials |
$2,144 |
H1 FY2025 Half Year Report
|
21 Feb 2025 8:20AM |
$3.570 |
$5.090 |
risen by
42.58%
|
|
Austal Limited (ASB) ORDINARY FULLY PAID |
Industrials |
$2,144 |
H1 FY2025 Appendix 4D
|
21 Feb 2025 8:19AM |
$3.570 |
$5.090 |
risen by
42.58%
|
|
ASB - Price-sensitive ASX Announcement
Full Release
Key Points
- The reporting period is from 1 July 2024 to 31 December 2024.
- Revenue from ordinary activities increased by 15% to $825,727.
- Profit after tax attributable to members rose by 109% to $25,113.
- Net profit for the period was $25,113, reflecting a 109% increase.
- No dividends were declared for FY2024 or FY2025 interim periods.
- Net tangible assets per share increased to 288 cents from 247 cents.
- Financial statements comply with AASB 134 Interim Financial Reporting.
- There were no qualifications noted in the audit or review.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
VRX Silica Limited (VRX) ORDINARY FULLY PAID |
Materials |
$33 |
General Meeting Notice and Access Letter
|
21 Feb 2025 8:19AM |
$0.040 |
$0.044 |
risen by
10%
|
|
VRX Silica Limited (VRX) ORDINARY FULLY PAID |
Materials |
$33 |
Notice of General Meeting/Proxy Form
|
21 Feb 2025 8:19AM |
$0.040 |
$0.044 |
risen by
10%
|
|
iCetana Limited (ICE) ORDINARY FULLY PAID |
Information Technology |
$7 |
Change of Director's Interest Notice
|
21 Feb 2025 8:19AM |
$0.020 |
$0.016 |
fallen by
20%
|
|
Monadelphous Group Limited (MND) ORDINARY FULLY PAID |
Industrials |
$1,585 |
Monadelphous Contracts Update
|
21 Feb 2025 8:19AM |
$16.280 |
$16.040 |
fallen by
1.47%
|
|
MND - Price-sensitive ASX Announcement
Full Release
Key Points
- Monadelphous awarded new contracts worth approximately $400 million.
- Seven-year maintenance and construction contract secured at Shell QGC's Curtis Island.
- Zenviron awarded contract for EnergyAustralia's 350 MW Wooreen Battery Energy Storage System.
- Contract awarded for structural remediation at Rio Tinto's mine sites in Pilbara.
- Additional outage contract secured at Loy Yang B power station.
- Contract for compressor station upgrades at Jemena's Eastern Gas Pipeline.
- Monadelphous has secured over $2 billion in new contracts since the beginning of the financial year.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Elanor Commercial Property Fund (ECF) FULLY PAID UNITS STAPLED SECURITIES |
Real Estate |
$248 |
Elanor Commercial Property Fund Investor Briefing
|
21 Feb 2025 8:19AM |
$0.605 |
$0.610 |
risen by
0.83%
|
|
EVZ Limited (EVZ) ORDINARY FULLY PAID |
Industrials |
$18 |
1HFY25 Investor Presentation
|
21 Feb 2025 8:18AM |
$0.195 |
$0.150 |
fallen by
23.08%
|
|
EVZ - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue decreased by 9% to $54.2 million in 1HFY25.
- EBITDA fell to $2.49 million from $2.76 million in 1HFY24.
- Profit before tax reduced significantly to $673,814.
- Net assets stood at $34 million with no debt and $10.7 million cash.
- Strong contract backlog of over $110 million supports future revenue.
- Operational expenses and investments for geographic expansion were incurred.
- The company aims for growth through business acquisitions and operational improvements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
EVZ Limited (EVZ) ORDINARY FULLY PAID |
Industrials |
$18 |
1HFY25 Appendix 4D and Half Year Report
|
21 Feb 2025 8:18AM |
$0.195 |
$0.150 |
fallen by
23.08%
|
|
EVZ - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue of $54.2 million decreased by 8.9% compared to the previous year.
- NPAT dropped by 50.3% to $673,814.
- Positive cash flow of $2.4 million for the first half.
- Earnings per share decreased to 0.56 cents.
- Total comprehensive income for the half-year was $1,061,395.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
AdAlta Limited (1AD) ORDINARY FULLY PAID |
Health Care |
$4 |
Application for quotation of securities - 1AD
|
21 Feb 2025 8:18AM |
$0.015 |
$0.006 |
fallen by
60%
|
|
Wisetech Global Limited (WTC) ORDINARY FULLY PAID |
Information Technology |
$31,783 |
Change in substantial holding
|
21 Feb 2025 8:17AM |
$121.700 |
$95.000 |
fallen by
21.94%
|
|
Latitude Group Holdings Limited (LFS) ORDINARY FULLY PAID |
Financials |
$1,190 |
LFS FY24 Management Discussion and Analysis
|
21 Feb 2025 8:17AM |
$1.150 |
$1.145 |
fallen by
0.43%
|
|
Resonance Health Limited (RHT) ORDINARY FULLY PAID |
Health Care |
$17 |
Half Year Results - Call Details
|
21 Feb 2025 8:17AM |
$0.055 |
$0.036 |
fallen by
34.55%
|
|
Latitude Group Holdings Limited (LFS) ORDINARY FULLY PAID |
Financials |
$1,190 |
LFS FY24 Investor Presentation
|
21 Feb 2025 8:17AM |
$1.150 |
$1.145 |
fallen by
0.43%
|
|
LFS - Price-sensitive ASX Announcement
Full Release
Key Points
- FY24 saw a year-on-year increase of 22% in key business drivers.
- Net interest margin improved significantly, influenced by pricing actions.
- Latitude maintained strong liquidity with a diverse funding platform.
- The company is focused on enhancing customer originations and total receivables.
- A positive outlook for 2025 is expected due to favorable macroeconomic conditions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
WA1 Resources Ltd (WA1) ORDINARY FULLY PAID |
Materials |
$785 |
West Arunta Project - Luni Assay Results
|
21 Feb 2025 8:17AM |
$12.990 |
$11.590 |
fallen by
10.78%
|
|
WA1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Exceptional high-grade niobium mineralisation zone defined at Luni.
- New assay results include significant Nb2O5 percentages from multiple drill holes.
- Drilling activities aimed at defining an optimal early-development scenario.
- An updated Mineral Resource estimate is anticipated in the first half of 2025.
- Field activities have recommenced with a focus on data collection and pre-development tasks.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Ramelius Resources Limited (RMS) ORDINARY FULLY PAID |
Materials |
$3,141 |
Appendix 4D and December 2024 Half Yearly Financial Report
|
21 Feb 2025 8:17AM |
$2.630 |
$2.710 |
risen by
3.04%
|
|
RMS - Price-sensitive ASX Announcement
Full Release
Key Points
- Ramelius produced 147,755 ounces of gold during the half-year ended 31 December 2024.
- The All-in Sustaining Cost (AISC) was A$1,699 per ounce.
- The company reported a net profit after tax (NPAT) of A$170.4 million, a 314% increase from the previous year.
- Revenue increased by 46% to A$507.96 million.
- Gold production guidance for the 2025 financial year is between 270,000 to 300,000 ounces.
- Mining operations commenced at the Cue Gold Mine during the reporting period.
- A successful Pre-Feasibility Study was conducted for the Rebecca-Roe Gold Project.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
AusGold Limited (AUC) ORDINARY FULLY PAID |
Materials |
$187 |
BMO GLOBAL METALS CONFERENCE, INVESTOR PRESENTATION
|
21 Feb 2025 8:17AM |
$0.470 |
$0.525 |
risen by
11.70%
|
|
Mayne Pharma Group Limited (MYX) ORDINARY FULLY PAID |
Health Care |
$569 |
Mayne Pharma enters Scheme Implementation Deed with Cosette
|
21 Feb 2025 8:16AM |
$5.410 |
$7.000 |
risen by
29.39%
|
|
MYX - Price-sensitive ASX Announcement
Full Release
Key Points
- Acquisition price of A$7.40 per share in cash.
- Consideration represents a significant premium to the pre-announcement share price.
- The Mayne Pharma Board unanimously recommends that shareholders vote in favour of the Scheme.
- Transaction is fully funded and subject to limited customary conditions.
- Independent expert's report to be provided to Mayne Pharma shareholders.
- Scheme Meeting expected to be held in late April to early May 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Latitude Group Holdings Limited (LFS) ORDINARY FULLY PAID |
Financials |
$1,190 |
LFS FY24 Results Announcement
|
21 Feb 2025 8:16AM |
$1.150 |
$1.145 |
fallen by
0.43%
|
|
LFS - Price-sensitive ASX Announcement
Full Release
Key Points
- Statutory NPAT from continuing operations of $30.6m, up from a loss of $102.7m in FY23
- Cash NPAT of $65.9m, up 139% compared to FY23
- Total volume of $8.2bn, up 13% YoY
- 265,000 new Latitude customer accounts opened, up 22% from prior year
- Total purchase volume of $6.7bn, up 10% YoY
- New personal and auto loan origination of $1.5bn, up 33% YoY
- Total gross receivables of $6.7bn, up 8% YoY
- Operating income margin of 11.3%, up 85bps YoY
- Cash operating expenses of $360 million, up 4% YoY
- Declared dividend of 3.00 cents per share, unfranked
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Latitude Group Holdings Limited (LFS) ORDINARY FULLY PAID |
Financials |
$1,190 |
Dividend/Distribution - LFS
|
21 Feb 2025 8:16AM |
$1.150 |
$1.145 |
fallen by
0.43%
|
|
Latitude Group Holdings Limited (LFS) ORDINARY FULLY PAID |
Financials |
$1,190 |
LFS FY24 Appendix 4E
|
21 Feb 2025 8:15AM |
$1.150 |
$1.145 |
fallen by
0.43%
|
|
LFS - Price-sensitive ASX Announcement
Full Release
Key Points
- Statutory profit increased to $30.6 million from a loss of $102.7 million.
- Cash net profit after tax rose to $65.9 million, a 139% increase.
- Revenue from ordinary activities reached $1,115.2 million, up 11.4%.
- Final unfranked dividend declared at 3.00 cents per share.
- Net tangible assets per security improved to $0.44.
- Tangible equity ratio closed at 7.1%.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
QBE Insurance Group Limited (QBE) ORDINARY FULLY PAID |
Financials |
$32,541 |
Changes to QBE Non-Executive Directors
|
21 Feb 2025 7:32AM |
$20.070 |
$21.550 |
risen by
7.37%
|
|
QBE Insurance Group Limited (QBE) ORDINARY FULLY PAID |
Financials |
$32,541 |
Presentation of QBE FY24 Results
|
21 Feb 2025 7:32AM |
$20.070 |
$21.550 |
risen by
7.37%
|
|
QBE - Price-sensitive ASX Announcement
Full Release
Key Points
- Net insurance revenue increased from $16,599M in FY23 to $17,807M in FY24.
- Gross written premium rose from $21,748M in FY23 to $22,395M in FY24.
- The combined operating ratio improved from 95.2% in FY23 to 93.1% in FY24.
- Net claims ratio decreased from 65.1% in FY23 to 63.2% in FY24.
- Adjusted profit after income tax for FY24 was $1,729M, up from $1,362M in FY23.
- The company plans to balance capital returns with growth opportunities in attractive markets.
- Strong focus on enhancing portfolio quality and sustainability in operations.
- Resilience in underwriting performance amidst challenging market conditions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.